血清CA19-9水平在胰腺癌预后判断中的应用进展(3)
[5]楼文晖.胰腺癌治疗进展——2008 ASCO回顾[J].中国实用外科杂志，2008，28(9)：743-745.[6]Ballehaninna UK，Chamberlain RS. The clinical utility of serum CA 19-9 in the diagnosis，prognosis and management of pancreatic adeno carcinoma：an evidence based appraisal [J]. J Gastrointest Oncol，2012， 3(2)：105-119.
[7]Abdel-Misih SR，Hatzaras I，Schmidt C，et al. Failure of normalization of CA19-9 following resection for pancreatic cancer is tantamount to metastatic disease [J]. Ann Surg Oncol ......
您现在查看是摘要页，全文长 3802 字符。